TNFRSF17 and Miyoshi myopathy: Despite different kinetics seen in MM cells expressing various baseline BCMA levels or % BCMA+ patient CD138+ cells, GSIs robustly upregulated mBCMA densities and downregulated sBCMA in all MM cell lines and patient MM cells, regardless of disease and drug resistance statuses.